← Leaderboards
Anisley Valenciaga
Ohio State University
$204,068
Attributed
$204,068
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $64.9K · FY2016–19$100K$75K$50K$25K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$204,068 · 1
By mechanism
F31$204,068 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Matthew D Ringel$21,305,885
- Ming You$26,875,453
- Michael R Grever$17,739,693
- Thomas S Lin$2,451,525
- Michael C Ostrowski$13,472,116
Others in their field
Top investigators on “Distant Metastasis”
- Mehmet Toner · Massachusetts General Hospital$16,752,352
- Robert A Weinberg · Whitehead Institute For Biomedical Res$15,112,834
- Xue-Ru Wu · Va Medical Center$13,379,919
- Donald L Morton · John Wayne Cancer Institute$13,160,403
- Lewis A Chodosh · University Of Pennsylvania$11,310,035
- Jing Yang · University Of California, San Diego$10,154,011
Research focus
Distant MetastasisDoseActionable MutationBaseBehaviorBiologicalApoptosisBiologyCalcitoninCancer CellCancer Cell LineCancer PatientCancer TherapyCdk6-Associated Protein P18Biological MarkersCell DeathCell LineCell ProliferationCellsCell SurvivalComparative Genomic HybridizationCorrelative StudyCyclinsDown-Regulation
Grant awards (4)
CDK9 and cyclin regulators in Medullary Thyroid Cancer$64,886
F31 · FY2019 · CA · contact PI
CDK9 and cyclin regulators in Medullary Thyroid Cancer$62,942
F31 · FY2018 · CA · contact PI
CDK9 and cyclin regulators in Medullary Thyroid Cancer$38,354
F31 · FY2017 · CA · contact PI
CDK9 and cyclin regulators in Medullary Thyroid Cancer$37,886
F31 · FY2016 · CA · contact PI